{"name":"ExCellThera inc.","slug":"excellthera-inc","ticker":"","exchange":"","domain":"excellthera.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNWTg4UDFHTWtMeFJJc1c3SFR2bmdGLVBEWDdzX2R3UGgtbmh0dUs3bHkzNWQwbVhCendkMk56Vm12dHRXR0gzbXVFMnlXVF9ReHNmSUw0T3VtSUs1QzU5b3gxU1M5ZFA2NlcxczdfVGs1TW5ZeUZCYmpodlQ0dno2Vlp4Xzllcm5xY2hSaE1XbGU?oc=5","date":"2026-02-17","type":"pipeline","source":"Pharmaceutical Technology","summary":"ExCellThera secures German NUB Status 1 listing for Zemcelpro - Pharmaceutical Technology","headline":"ExCellThera secures German NUB Status 1 listing for Zemcelpro","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxObTQwa0p5cW40UDNmUVZrMGRXUldQNy1wM1RIU09rYkZTVjVJSWdSb1ZfZGtPZXFaX2lTVTRMNEtYc0d6WjF3TTZLSWZDd3UySkpPZTFDVFJwOVlvX3hicFhzVlp3a25xOEtnemhJT2QxcUFZMmJaSXNLXy1tRThDZFpBYS13cHJiTVlhNGNERTlaOG5zT1lGdlEzODhIaUZhcUxVUnNjMUZZYlY0QlVz?oc=5","date":"2026-02-16","type":"pipeline","source":"PR Newswire","summary":"Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany - PR Newswire","headline":"Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOQ2d2eWhMa1RnUm9rdHlibmRDYWhsLVJ0SVZpbW1xMDhXNXEwUVpJQTg2SnBxSEFtTTZCZ18xNDdnVXhhb3pQUzh3NUFCeDlMck5NS1BXNVEzT1V2S3lxblhFNTQ2RHBadDkzcEpyTVVkWG5UYlB0NGQ1dWd4Y0ZGdUJEeGkzb0pSNnc?oc=5","date":"2025-08-28","type":"pipeline","source":"Pharmaceutical Technology","summary":"ExCellThera secures EC authorisation for Zemcelpro cell therapy - Pharmaceutical Technology","headline":"ExCellThera secures EC authorisation for Zemcelpro cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPZ2lXemhPcHZXd1A1WVpUZ3pLZlhPenMxOWp2UU9SaHVabUJweFI3TW55cWU1d1JyTDdBS182alVqTXZWWDRIcGptSXozVVFsRXViOVRKcUc5dEgzd1lCb2RUZnlYSXNzUVRMenZvaG1aR1VmbnB3X3lIOHJzdFNFcnN5ZzVZU3lEUDJmaVVXRTFQWHlaTjZBWmdJbFkwOW9PR0xXZTJ4RXlaLWps?oc=5","date":"2025-08-27","type":"pipeline","source":"Fierce Pharma","summary":"ExCellThera's novel blood cancer stem cell therapy Zemcelpro earns EU nod - Fierce Pharma","headline":"ExCellThera's novel blood cancer stem cell therapy Zemcelpro earns EU nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxORjJ0Wm41ajVycjA4NTJxWm4xWlo3OEp4ZGVRdkNraHI1OTlaMDRsWGFUZHdCT2JQN1lPTTNTc2hTdnEtMk9OejRCNjRYSFJVRnFFRXM2ZEZsbEo1eFdfemJUajZCMW9oS2VIUGpvWl9HMVAzWmNhZENyYVYtS3hKVDJsaDBWZXVwOGZFcDlrUHBPeVd4d2NidHByVk9pRXl0TXRGcUEtYi14TFg3RnY3WFM5M2tfRUJ2ZHlUTldWM2ROdXdJY0pPODFfcWc1VlV2NkZHbGZQMEwtd0ZwcWNhOTlWMUNELUlNenZWbjFTckdUc2U4RFhwREpYTkpMS1FESk5pZmpWVW9NaE9uUE1KRnBTek85WVR3M3R1Z1NKZXd0RTN0Y3VFUlBUeHhiR1hGQ0tsbQ?oc=5","date":"2025-08-27","type":"pipeline","source":"PR Newswire","summary":"Zemcelpro® (UM171 Cell Therapy) receives EC authorization as the first and only cell therapy for blood cancer patients without access to suitable donor cells - PR Newswire","headline":"Zemcelpro® (UM171 Cell Therapy) receives EC authorization as the first and only cell therapy for blood cancer patients w","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPbnE3MlRucG5odHU5ZE0zaXV3R0F1aHVqazJPTEhjS2c4UWpRSW9fVVVLRVdLQnNOaHpTdHowNFdIZ3dNcnc5VXYzRFpBUmtSbXR4Rm92MHN2MGIwVmhlYVU2dFRuZTdjT1ZKMHgwU1BFWEF0OUhwUWo4RUNuOHNLTDVQSF9PdmhQZzRZ?oc=5","date":"2025-08-27","type":"pipeline","source":"Université de Montréal","summary":"UM171: first Europe, then Canada - Université de Montréal","headline":"UM171: first Europe, then Canada - Université de Montréal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQUc3djUxQjd4ZHZudjBBRVNlSExveEdiOEF2QlU0a015dWxVNjMwajFpQ2pYWTljZGhuRldFMTdWc2hKUlczTkdRSmhTSHI4SVVucmtBTXlEMDgtS1dzS0hHNDFYbTY2dEp6N045M3FuMVBJTzhYdHAtSk1wcnBoTnhtV2dOVTdxM2RUNFZfNXdsRlpvRVA0eWdCa2d2UEtSbnpaM2VIXzR3dEU?oc=5","date":"2025-06-20","type":"pipeline","source":"Fierce Pharma","summary":"Europe's CHMP gives thumbs up to ExCellThera's blood cancer cell therapy Zemcelpro - Fierce Pharma","headline":"Europe's CHMP gives thumbs up to ExCellThera's blood cancer cell therapy Zemcelpro","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQZndjc1JrLUlHN2t6YWVrdHJfZUJtdU1ORG1VcmRINlU0am0zU3FkZW93WF84cFdPX3p5Zl9ZdFJ0UFVYS0hsT3hsVjhIb3NGY3RpRTlWSG4zQktBRlhIRnZtTjRCNERadndUanhLY29RNFhqc2RhLVVNc3lqSjl2NGlGREQ3RTVWcUNxNkJINGNFYlR5Xy1kR050ZmNKam4yeURHOXNDcDc5S19HemNv?oc=5","date":"2025-06-20","type":"pipeline","source":"World Pharmaceutical Frontiers","summary":"ExCellThera’s Zemcelpro receives positive CHMP opinion for EU market - World Pharmaceutical Frontiers","headline":"ExCellThera’s Zemcelpro receives positive CHMP opinion for EU market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPa0pwM3dGRk1mZHhQQWFyYTZTLVBIS1lNTDBTeS02SXNDWVFmQ2N0cFdWUzFRVG9rLUR1d1d5a3NXT1FjYU05Y1ljMlB3QWlyamx2dTZLVm9HUTFqMkVEbHVMWkd2eWd4dGNUQkRfSUV0X2xUcGVhWVpUTHBoa3ZHVEJia3FVMmxYbHZmQm41dzJRQ1U1RENKZTI0Y2ZEdw?oc=5","date":"2019-11-06","type":"trial","source":"Fierce Biotech","summary":"ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer - Fierce Biotech","headline":"ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}